AMENDMENT NO. 2 TO THIRD AMENDED AND RESTATED STOCKHOLDERS' RIGHTS AGREEMENT This Amendment No. 2 dated as of December 6, 1996 (the "Amendment") to the Third Amended and Restated Stockholders Rights Agreement dated as of May 29, 1996, as amended by...
Exhibit 10.27
AMENDMENT NO. 2 TO
THIRD AMENDED AND RESTATED STOCKHOLDERS' RIGHTS AGREEMENT
This Amendment No. 2 dated as of December 6, 1996 (the
"Amendment") to the Third Amended and Restated Stockholders Rights Agreement
dated as of May 29, 1996, as amended by Amendment No. 1 dated as of May 31, 1996
(as heretofore amended, the "Rights Agreement"), is entered into by and among
EPIX Medical, Inc., a Delaware corporation (the "Company"), holders of shares of
the Company's Series A Convertible Preferred Stock, $.01 par value per share
(the "Series A Preferred"), and warrants convertible into Series A Preferred,
holders of the Company's Series B Convertible Preferred Stock, $.01 par value
per share (the "Series B Preferred"), and warrants convertible into Series B
Preferred, holders of the Company's Series C Convertible Preferred Stock, $.01
par value per share (the "Series C Preferred"), and warrants convertible into
Series C Preferred, holders of the Company's Series D Convertible Preferred
Stock, $.01 par value per share (the "Series D Preferred"), and warrants
convertible into Series D Preferred, and the holder of the Company's Series E
Convertible Preferred Stock, $.01 par value per share ("Series E Preferred")
listed on Schedule A to the Rights Agreement. All capitalized words and terms
used in this Amendment and not defined herein shall have the respective meanings
ascribed to them in the Rights Agreement.
WITNESSETH:
WHEREAS, the Company has recently changed its name from Metasyn, Inc. to
EPIX Medical, Inc.; and
WHEREAS, the Company has recently increased the number of shares authorized
for issuance under its 1992 Equity Incentive Plan.
NOW THEREFORE, in consideration of the mutual promises, covenants and
conditions hereinafter set forth and other good and valuable consideration, the
parties hereto agree as follows:
1. Amendment to Rights Agreement. The Rights Agreement is hereby amended as
follows:
Section 3. Right of First Refusal. That the number "1,749,852" on the 14th
line of Section 3(b) is hereby deleted and replaced with "2,299,852".
2. No Other Amendments. There have been no other changes, modifications or
alterations to the Rights Agreement except as amended hereby.
3. Entire Agreement. The Rights Agreement, as amended hereby, embodies the
entire agreement and understanding between the parties hereto with respect to
the subject matter hereof and supersedes all prior agreements and understandings
relating to such subject matter.
4. Counterparts. This Amendment may be executed in several counterparts,
each of which shall be deemed an original, but all of which together shall
constitute one and the same instrument.
5. Headings. The headings of the sections, subsections, and paragraphs of
this Amendment have been added for convenience only and shall not be deemed to
be a part of this Amendment.
IN WITNESS WHEREOF, the undersigned have hereunto set their hands as of the
day and year first above written.
EPIX MEDICAL, INC.
By: /s/ ▇▇▇▇▇▇▇ ▇. ▇▇▇▇
------------------------
▇▇▇▇▇▇▇ ▇. ▇▇▇▇
President
/s/ ▇▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇▇
-------------------------
▇▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇▇
- 2 -
SIGNATURE PAGE TO AMENDMENT NO. 2 TO
THIRD AMENDED AND RESTATED STOCKHOLDERS' RIGHTS AGREEMENT
SUMMIT PHARMACEUTICALS
INTERNATIONAL CORPORATION
By: /s/ ▇. ▇▇▇▇▇
---------------------
Name: ▇. ▇▇▇▇▇
Title: President and CEO
NIPPON SHOJI KAISHA, LTD.
By: /s/ ▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇
----------------------
Name: ▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇
Title: Managing Director
- 3 -
SIGNATURE PAGE TO AMENDMENT NO. 2 TO
THIRD AMENDED AND RESTATED STOCKHOLDERS' RIGHTS AGREEMENT
ACCEL IV L.P.
By: Accel IV Associates L.P.,
its General Partner
By: /s/ ▇▇▇▇ ▇▇▇▇▇
-------------------------------
Name: ▇▇▇▇ ▇▇▇▇▇
Title: General Partner
ACCEL INVESTORS '93 L.P.
By: /s/ ▇. ▇▇▇▇▇▇ Sednaoui
-------------------------------
Name: ▇. ▇▇▇▇▇▇ Sednaoui
Title: General Partner
ACCEL KEIRETSU L.P.
By: Accel Partners & Co., Inc.,
its General Partner
By: /s/ ▇. ▇▇▇▇▇▇ Sednaoui
-------------------------------
Name: ▇. ▇▇▇▇▇▇ Sednaoui
Title: General Partner
▇▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇▇▇▇ PARTNERS
By: /s/ ▇. ▇▇▇▇▇▇ Sednaoui
-------------------------------
Name: ▇. ▇▇▇▇▇▇ Sednaoui
Title: General Partner
PROSPER PARTNERS
By: /s/ ▇. ▇▇▇▇▇▇ Sednaoui
-------------------------------
Name: ▇. ▇▇▇▇▇▇ Sednaoui
Title: Attorney-in-Fact
- 4 -
SIGNATURE PAGE TO AMENDMENT NO. 2 TO
THIRD AMENDED AND RESTATED STOCKHOLDERS' RIGHTS AGREEMENT
*
-------------------------------
Neill ▇. ▇▇▇▇▇▇▇▇▇▇
*
-------------------------------
G. ▇▇▇▇▇ ▇▇▇▇▇▇▇▇
*
-------------------------------
▇▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇
*
-------------------------------
Gabrieli Family Foundation
*
-------------------------------
▇▇▇▇▇ ▇. ▇▇▇▇▇
*
-------------------------------
C. ▇▇▇▇▇▇▇▇ ▇▇▇▇
*
-------------------------------
▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇▇▇
*
-------------------------------
▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇▇
*
-------------------------------
▇▇▇▇ ▇. ▇▇▇▇▇▇▇
*
-------------------------------
▇▇▇▇▇▇ ▇. ▇▇▇▇▇
*
-------------------------------
▇▇▇▇▇▇▇ ▇. ▇▇▇▇▇
- 5 -
SIGNATURE PAGE TO AMENDMENT NO. 2 TO
THIRD AMENDED AND RESTATED STOCKHOLDERS' RIGHTS AGREEMENT
*
-------------------------------
▇▇▇▇ ▇. ▇▇▇▇▇▇▇
*
-------------------------------
▇▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇▇
*
-------------------------------
Belisarius Corporation
*
-------------------------------
▇▇▇▇▇▇▇ Corporation
*
-------------------------------
▇▇▇▇▇ ▇. ▇▇▇▇▇▇▇▇▇
*
-------------------------------
▇▇▇▇ ▇. ▇▇▇▇
*
-------------------------------
▇▇▇▇▇▇ ▇. ▇. ▇▇▇▇▇▇▇▇
*
-------------------------------
▇▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇▇▇▇▇
*
-------------------------------
▇▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇
*
-------------------------------
Brimstone Island Co. L.P.
*
-------------------------------
▇▇▇▇▇▇▇ ▇▇▇▇▇▇
*
-------------------------------
▇▇▇▇ ▇▇▇▇▇▇
- 6 -
SIGNATURE PAGE TO AMENDMENT NO. 2 TO
THIRD AMENDED AND RESTATED STOCKHOLDERS' RIGHTS AGREEMENT
* By: /s/ ▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇▇▇
-------------------------------
Name: ▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇▇▇
Title: Attorney-in-Fact
/s/ ▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇▇▇
-------------------------------
▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇▇▇
BESSEMER VENTURE PARTNERS III L.P.
By: Deer III & Co.,
General Partner
By: /s/ ▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇▇▇
-------------------------------
Name: ▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇▇▇
Title: General Partner
BVP III SPECIAL SITUATIONS L.P.
By: Deer III & Co.,
General Partner
By: /s/ ▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇▇▇
-------------------------------
Name: ▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇▇▇
Title: General Partner
- 7 -
SIGNATURE PAGE TO AMENDMENT NO. 2 TO
THIRD AMENDED AND RESTATED STOCKHOLDERS' RIGHTS AGREEMENT
DOMINION VENTURES, INC.
By: /s/ ▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇
-------------------------------
Name: ▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇
Title:
DOMINION FUND II
By: /s/ ▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇
-------------------------------
Name: ▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇
Title:
- 8 -
SIGNATURE PAGE TO AMENDMENT NO. 2 TO
THIRD AMENDED AND RESTATED STOCKHOLDERS' RIGHTS AGREEMENT
ROVENT II LIMITED PARTNERSHIP
By: Advent International Limited Partnership,
General Partner
By: Advent International Corporation, General
Partner
By: /s/ ▇▇▇▇ ▇▇▇▇▇▇▇
-------------------------------------
Name: ▇▇▇▇ ▇▇▇▇▇▇▇
Title: Investment Manager
ADVENT PERFORMANCE MATERIALS
LIMITED PARTNERSHIP
By: Advent International Limited Partnership,
General Partner
By: Advent International Corporation, General
Partner
By: /s/ ▇▇▇▇ ▇▇▇▇▇▇▇
-------------------------------------
Name: ▇▇▇▇ ▇▇▇▇▇▇▇
Title: Investment Manager
ADWEST LIMITED PARTNERSHIP
By: Advent International Limited Partnership,
General Partner
By: Advent International Corporation, General
Partner
By: /s/ ▇▇▇▇ ▇▇▇▇▇▇▇
-------------------------------------
Name: ▇▇▇▇ ▇▇▇▇▇▇▇
Title: Investment Manager
ADVENT PARTNERS LIMITED
PARTNERSHIP
By: Advent International Corporation, General
Partner
By: /s/ ▇▇▇▇ ▇▇▇▇▇▇▇
-------------------------------------
Name: ▇▇▇▇ ▇▇▇▇▇▇▇
Title: Investment Manager
- 9 -
SIGNATURE PAGE TO AMENDMENT NO. 2 TO
THIRD AMENDED AND RESTATED STOCKHOLDERS' RIGHTS AGREEMENT
FIDELITY VENTURES, LTD.
By: /s/ ▇▇▇▇ ▇▇▇▇▇▇▇▇
------------------------------------
Name: ▇▇▇▇ ▇▇▇▇▇▇▇▇
Title: Vice President
DAICHII RADIOISOTOPE LABORATORIES, LTD.
By: /s/ ▇▇▇▇▇ ▇▇▇▇▇
------------------------------------
Name: ▇▇▇▇▇ ▇▇▇▇▇, M.D.
Title: President and Chief Executive Officer